Multiple spontaneous hemorrhages after commencing warfarin therapy

Area of Science:

• Geriatric Medicine
• Cardiology
• Pharmacology

Background:

• Atrial fibrillation (AF) with rapid ventricular response is a common cause of heart failure, particularly in the elderly.
• Warfarin is frequently prescribed for stroke prevention in AF patients.
• Renal dysfunction is prevalent in older adults and can affect drug metabolism and excretion.

Observation:

• A 94-year-old Japanese woman with renal dysfunction presented with heart failure due to AF.
• Warfarin was initiated for stroke risk, but she developed severe bleeding (brachial and retroperitoneal hemorrhage) and shock within 4 days.
• The patient recovered after blood transfusion and vitamin K2 administration, with no evidence of over-anticoagulation.

Findings:

• Bleeding complications during warfarin therapy are more common in elderly patients with reduced glomerular filtration rates.
• The initial 30 days of warfarin treatment represent a high-risk period for hemorrhage.
• This case highlights the potential for serious bleeding events even when anticoagulation levels are within the therapeutic range.

Implications:

• Physicians must exercise heightened vigilance for unexpected bleeding in elderly patients commencing warfarin, especially those with renal impairment.
• Prompt recognition and management, including potential reversal of anticoagulation, are essential for patient safety.
• Further research into optimizing warfarin dosing and monitoring strategies in vulnerable elderly populations is warranted.